New insights into genetic and molecular mechanisms of brain degeneration in tauopathies

Journal of Chemical Neuroanatomy

Volumn 20, Issue 3-4, 2000, Pages 225-244

  Forman, Mark S ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Dementia; Mutation; Neurodegenerative diseases; Neurofibrillary tangles; Pathology; Tau Protein

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN DEGENERATION; CHROMOSOME 17; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DISEASE COURSE; DNA POLYMORPHISM; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PARKINSONISM; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; RISK FACTOR; RNA SPLICING;

ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; TAU PROTEINS;

EID: 0034469810     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(00)00100-9     Document Type: Article

References (192)

1. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
2. Structure and novel exons of the human tau gene
3. The tau mutation (val337met) disrupts cytoskeletal networks of microtubules
4. Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
5. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations
6. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
7. Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids
8. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5
9. Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European study group on atypical parkinsonism consortium
10. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline
11. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
12. Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration
13. The distribution of tau in the mammalian central nervous system
14. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
15. Chromosome 17 and hereditary dementia: Linkage studies in three non-Alzheimer families and kindreds with late-onset FAD
16. The tau gene in progressive supranuclear palsy: Exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases
17. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
18. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
19. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease
20. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
21. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau
22. Tau protein binds to microtubules through a flexible array of distributed weak sites
23. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
24. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
25. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
26. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin
27. Genetic evidence for the involvement of tau in progressive supranuclear palsy
28. Pick's disease. Histological and clinical correlations
29. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
30. Primary structure of high molecular weight tau present in the peripheral nervous system
31. Straight and paired helical filaments in Alzheimer disease have a common structural unit
32. Image reconstruction of the Alzheimer paired helical filament
33. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
34. Determinants of 4 repeat tau expression: Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion
35. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation
36. Specific pathological tau protein variants characterize Pick's disease
37. A mutation at codon 279 (N279K) in exon 10 of the tau gene causes a tauopathy with dementia and supranuclear palsy
38. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions
39. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy
40. Pick's disease: A modern approach
41. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
42. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau
43. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption
44. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes
45. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism
46. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans
47. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: Differentiation from progressive supranuclear palsy
48. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration
49. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type
50. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
51. Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation
52. Pro-apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism
53. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
54. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia
55. High molecular weight tau: Preferential localization in the peripheral nervous system
56. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease
57. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases
58. Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization
59. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments
60. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system
61. Tau gene mutation in familial progressive subcortical gliosis
62. Molecular dissection of the paired helical filament
63. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
64. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain
65. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau
66. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly
67. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau
68. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
69. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis
70. Dementia as the most common presentation of cortical-basal ganglionic degeneration
71. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10
72. Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease
73. Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ
74. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localization of the kinase
75. Altered microtubule organization in small-calibre axons of mice lacking tau protein
76. Genetic classification of primary neurodegenerative disease
77. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
78. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10
79. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)
80. Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: A genetic and clinicopathological study of three Dutch families
81. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene
82. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains
83. The tau gene A0 allele and progressive supranuclear palsy
84. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3
85. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons
86. Tau-based neurofibrillary lesions
87. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
88. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
89. Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke Family 1684
90. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
91. A distinct familial presenile dementia with a novel missense mutation in the tau gene
92. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice
93. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
94. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17
95. Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins
96. Fetal-type phosphorylation of the tau in paired helical filaments
97. Paired helical filaments in electron microscopy of Alzheimer's disease
98. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule
99. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
100. The carboxyl third of tau is tightly bound to paired helical filaments
101. Epitopes that span the tau molecule are shared with paired helical filaments
102. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration
103. Tau polymorphisms are not associated with Alzheimer's disease
104. The microtubule binding domain of tau protein
105. A68: A major subunit of paired helical filaments and derivatized forms of normal tau
106. Hereditary dysphasic disinhibition dementia: A frontotemporal dementia linked to 17q21-22
107. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
108. Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein tau
109. Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease
110. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain
111. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop
112. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders
113. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes
114. Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: The effects on the organization and stability of microtubules
115. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
116. Clinical and neuropathological criteria for frontotemporal dementia
117. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes 1
118. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
119. Dementia of frontal type and dementias with subcortical gliosis
120. Molecular basis of the neurodegenerative disorders
121. Spinal cord neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia complex: An immunohistochemical study
122. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
123. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
124. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases
125. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons
126. Tau pathology in a family with dementia and a P301L mutation in tau
127. Progressive supranuclear palsy: Earlier age of onset in patients with the tau protein A0/A0 genotype
128. Hyperphosphorylation of tau in PHF
129. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases
130. Mutation in the tau exon 10 splice site region in familial frontotemporal dementia
131. Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17
132. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits
133. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations
134. From genotype to phenotype: A clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation
135. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
136. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2
137. Significant association between the tau gene A0/A0 genotype and Parkinson's disease
138. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
139. Über die bejiehungen der senilen hirnatrophie zur aphasie
140. Tau is a candidate gene for chromosome 17 frontotemporal dementia
141. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
142. Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment
143. Corticodentatonigral degeneration with neuronal achromasia: A progressive disorder in late adult life
144. Corticodentatonigral degeneration with neuronal achromasia
145. Autosomal dominant dementia with widespread neurofibrillary tangles
146. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration")
147. Reactivating kinase/p38 phosphorylates tau protein in vitro
148. Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein
149. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands
150. Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: A novel action of R406W mutation
151. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau
152. The origins of Alzheimer disease: A is for amyloid
153. Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome project
154. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5
155. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases
156. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively "exon 10" isoforms
157. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau
158. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues
159. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly
160. The neuropathology of chromosome 17-linked dementia
161. Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases
162. Immunocytochemical study of ballooned neurons in cortical degeneration with neuronal achromasia
163. Interaction of neuronal cdc2 like protein kinase with microtubule associated protein tau
164. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle
165. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies
166. FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation
167. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles
168. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau
169. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
170. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
171. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations
172. Progressive supranuclear palsy
173. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
174. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala
175. Involvement of tau protein kinase I in paired helical filament-like phosphorylation of the juvenile tau in rat brain
176. Regional distribution and biochemical characteristics of high molecular weight tau in the nervous system
177. Polypurine sequences within a downstream exon function as a splicing enhancer
178. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome
179. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice
180. Paired helical filament tau in Alzheimer's disease. The kinase connection
181. Phenotypic variation in hereditary frontotemporal dementia with tau mutations
182. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17
183. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: Evidence for general cortical involvement
184. In vivo phosphorylation sites in fetal and adult rat tau
185. A protein factor essential for microtubule assembly
186. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21
187. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22
188. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease
189. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II
190. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration
191. A novel mutation at posititon +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)
192. Tau in paired helical filaments is functionally distinct from fetal tau: Assembly incompetence of paired helical filament-tau